Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction.
Martino PepeAlessandro CafaroValeria ParadiesNicola SignoreFrancesco AddabboAlessandro Santo BortoneEliano Pio NavareseGaetano ContegiacomoCinzia ForleoFrancesco BartolomucciOttavio Di CilloFrancesco Paolo BianchiDomenico ZannaStefano FavalePublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
This observational study suggests that the angiographic benefit of P2Y12 -I administration is time-dependent: longer pretreatment improves coronary reperfusion in terms of pre- and post-pPCI TFG and STR.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- coronary artery disease
- end stage renal disease
- acute myocardial infarction
- ejection fraction
- newly diagnosed
- chronic kidney disease
- st segment elevation myocardial infarction
- liver failure
- acute coronary syndrome
- peritoneal dialysis
- prognostic factors
- atrial fibrillation
- aortic stenosis
- heart failure
- cerebral ischemia
- blood brain barrier
- acute respiratory distress syndrome
- transcatheter aortic valve replacement
- aortic valve